MILLENNIUM MANAGEMENT LLC - 11 Feb 2026 SCHEDULE 13G/A Report for Supernus Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (SUPN)

Filing manager: MILLENNIUM MANAGEMENT LLC
Reporting owner: Millennium Management LLC
Security: Supernus Pharmaceuticals, Inc. Common Stock, par value $0.001 per share
Symbol: SUPN
Shares outstanding: 57,572,193 shares
Disclosed shares: 3,281,615 shares
Ownership percentage: 5.7%
Form type: SCHEDULE 13G/A
Filing time: 18 Feb 2026, 16:38:59 UTC
Event date: 11 Feb 2026
Previous filing: 02 Feb 2026
SEC filing: View on sec.gov

Key filing fact

MILLENNIUM MANAGEMENT LLC disclosed 5.7% ownership in Supernus Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (SUPN) on 11 Feb 2026.

Key facts

MILLENNIUM MANAGEMENT LLC filed SCHEDULE 13G/A for Supernus Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (SUPN).
Disclosed ownership: 5.7%.
Date of event: 11 Feb 2026.

This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
You can verify ownership claims directly against the original SEC filing.

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

Reporting persons

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name	Ownership	Shares Owned	shared voting power	Signature	Title
Integrated Core Strategies (US) LLC	4.9%	2,817,883	2,817,883	/s/ Gil Raviv	Gil Raviv, Global General Counsel
Millennium Management LLC	5.7%	3,281,615	3,281,615	/s/ Gil Raviv	Gil Raviv, Global General Counsel
Millennium Group Management LLC	5.7%	3,281,615	3,281,615	/s/ Gil Raviv	Gil Raviv, Global General Counsel
Israel A. Englander	5.7%	3,281,615	3,281,615	/s/ Israel A. Englander	Israel A. Englander

CIK / CUSIP context first

Broader feeds